Cargando…

The Molecular Signature More Than the Site of Localization Defines the Origin of the Malignancy

The diagnosis of the primary origin of metastases to the thyroid gland is not easy, in particular in case of concomitant lung adenocarcinoma which shares several immunophenotypical features. Although rare, these tumors should be completely characterized in order to set up specific therapies. This is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matrone, Antonio, Torregrossa, Liborio, Sensi, Elisa, Cappellani, Daniele, Baronti, Walter, Ciampi, Raffaele, Molinaro, Eleonora, Ugolini, Clara, Aghababyan, Aleksandr, De Napoli, Luigi, Latrofa, Francesco, Materazzi, Gabriele, Basolo, Fulvio, Vitti, Paolo, Elisei, Rossella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928194/ https://www.ncbi.nlm.nih.gov/pubmed/31921647 http://dx.doi.org/10.3389/fonc.2019.01390

Ejemplares similares

Core Needle Biopsy Can Early and Precisely Identify Large Thyroid Masses
por: Matrone, Antonio, et al.
Publicado: (2022)

RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastases
por: Romei, Cristina, et al.
Publicado: (2018)

MON-524 Prospective Evaluation of Patients with Encapsulated Classical Variant of Papillary Thyroid Cancer and Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): Have They A Similar Prognosis?
por: Giani, Carlotta, et al.
Publicado: (2020)

Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience
por: Romei, Cristina, et al.
Publicado: (2018)

Impact of Advanced Age on the Clinical Presentation and Outcome of Sporadic Medullary Thyroid Carcinoma
por: Matrone, Antonio, et al.
Publicado: (2020)

Clinical-Pathological and Molecular Evaluation of 451 NIFTP Patients from a Single Referral Center
por: Vignali, Paola, et al.
Publicado: (2022)

Higher RET Gene Expression Levels Do Not Represent anAlternative RET Activation Mechanism in Medullary Thyroid Carcinoma
por: Mulè, Chiara, et al.
Publicado: (2021)

Molecular Alterations in Relation to Histopathological Characteristics in a Large Series of Pediatric Papillary Thyroid Carcinoma from a Single Institution
por: Macerola, Elisabetta, et al.
Publicado: (2021)

Poorly Differentiated and Anaplastic Thyroid Cancer: Insights into Genomics, Microenvironment and New Drugs
por: Prete, Alessandro, et al.
Publicado: (2021)

Genetic Landscape of Somatic Mutations in a Large Cohort of Sporadic Medullary Thyroid Carcinomas Studied by Next-Generation Targeted Sequencing
por: Ciampi, Raffaele, et al.
Publicado: (2019)

Usefulness of second (131)I treatment in biochemical persistent differentiated thyroid cancer patients
por: Gambale, Carla, et al.
Publicado: (2023)

RET mutated C-cells proliferate more rapidly than non-mutated neoplastic cells
por: Romei, Cristina, et al.
Publicado: (2021)

BRAF K601E Mutation in Oncocytic Carcinoma of the Thyroid: A Case Report and Literature Review
por: Matrone, Antonio, et al.
Publicado: (2023)

Outcomes of the Tall-Cell Variant of Papillary Thyroid Carcinoma in Patients with Different Ages: A 17-Year Mono-Institutional Experience
por: Proietti, Agnese, et al.
Publicado: (2023)

RET Copy Number Alteration in Medullary Thyroid Cancer Is a Rare Event Correlated with RET Somatic Mutations and High Allelic Frequency
por: Ramone, Teresa, et al.
Publicado: (2020)

DICER1 somatic mutations strongly impair miRNA processing even in benign thyroid lesions
por: Poma, Anello Marcello, et al.
Publicado: (2019)

Predictive Biomarkers in Thyroid Cancer
por: Macerola, Elisabetta, et al.
Publicado: (2022)

Salvage total thyroidectomy for amiodarone-induced thyrotoxicosis in a SARS-CoV-2 positive patient: results of the viral genome research on the pathology sample of this destructive thyroiditis
por: Cappellani, Daniele, et al.
Publicado: (2022)

Clinical–Pathological Features and Treatment Outcome of Patients With Hobnail Variant Papillary Thyroid Carcinoma
por: Poma, Anello Marcello, et al.
Publicado: (2022)

Lung Recurrence of Papillary Thyroid Cancer Diagnosed With Antithyroglobulin Antibodies After 10 Years From Initial Treatment
por: Viola, David, et al.
Publicado: (2018)

Lenvatinib Administered via Nasogastric Tube in Poorly Differentiated Thyroid Cancer
por: Molinaro, Eleonora, et al.
Publicado: (2019)

Active Surveillance in RET Gene Carriers Belonging to Families with Multiple Endocrine Neoplasia
por: Prete, Alessandro, et al.
Publicado: (2021)

Using The Cancer Genome Atlas data to refine the 8th edition of the American Joint Committee on Cancer staging for papillary thyroid carcinoma
por: Poma, Anello Marcello, et al.
Publicado: (2020)

Molecular Genetics of Follicular-Derived Thyroid Cancer
por: Macerola, Elisabetta, et al.
Publicado: (2021)

Bilateral testicular metastases of medullary thyroid carcinoma in an adult male with multiple endocrine neoplasia 2A syndrome: case report and review of literature
por: Orsolini, Francesca, et al.
Publicado: (2022)

A six-gene panel to label follicular adenoma, low- and high-risk follicular thyroid carcinoma
por: Poma, Anello Marcello, et al.
Publicado: (2017)

A New MEN2 Syndrome with Clinical Features of Both MEN2A and MEN2B Associated with a New RET Germline Deletion
por: Giani, Carlotta, et al.
Publicado: (2020)

MicroRNA expression profiling of RAS-mutant thyroid tumors with follicular architecture: microRNA signatures to discriminate benign from malignant lesions
por: Macerola, E., et al.
Publicado: (2023)

The italian consensus for the classification and reporting of thyroid cytology: Cytohistologic and molecular correlations on 37,371 nodules from a single institution
por: Torregrossa, Liborio, et al.
Publicado: (2022)

Hippo pathway affects survival of cancer patients: extensive analysis of TCGA data and review of literature
por: Poma, Anello Marcello, et al.
Publicado: (2018)

Down-regulation of miR-7-5p and miR-548ar-5p predicts malignancy in indeterminate thyroid nodules negative for BRAF and RAS mutations
por: Macerola, Elisabetta, et al.
Publicado: (2022)

The 5(th) edition of WHO classification of tumors of endocrine organs: changes in the diagnosis of follicular-derived thyroid carcinoma
por: Basolo, Fulvio, et al.
Publicado: (2023)

MON-495 Influence of Lymphocytic Thyroiditis at Histology and Serum Thyroglobulin Autoantibodies on the Course of Papillary Thyroid Carcinoma
por: Viola, Nicola, et al.
Publicado: (2020)

Response to Letter to the Editor From Green and Gosmanov: “Tall Cell Percentage Alone in PTC Without Aggressive Features Should not Guide Patients’ Clinical Management”
por: Viola, David, et al.
Publicado: (2022)

OR21-01 Pre-Operative Calcitonin Value as a Predictive Factor of Cancer Related Death in Sporadic Medullary Thyroid Carcinoma
por: Matrone, Antonio, et al.
Publicado: (2020)

In Graves’ disease, thyroid autoantibodies and ultrasound features correlate with distinctive histological features
por: Brancatella, A., et al.
Publicado: (2023)

Twenty-Five Years Experience on RET Genetic Screening on Hereditary MTC: An Update on The Prevalence of Germline RET Mutations
por: Elisei, Rossella, et al.
Publicado: (2019)

MON-537 Primary Adrenal Insufficiency During Tyrosine Kinase Inhibitors Treatment in Advanced Thyroid Cancer Patients
por: Valerio, Laura, et al.
Publicado: (2020)

A nonfunctioning parathyroid carcinoma misdiagnosed as a follicular thyroid nodule
por: Cetani, Filomena, et al.
Publicado: (2015)

Assessing mPTC Progression during Active Surveillance: Volume or Diameter Increase?
por: Campopiano, Maria Cristina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vi6ejkmnp6104v6kv1on0tsam8